Furthermore, silencing of COMMD7 inhibits hepatocellular carcinoma (HCC) cell proliferation, migration, and invasion by suppressing NF‐κB p65,21 thereby acting as a new molecular target in the late stages of pancreatic ductal adenocarcinoma.22 Here, NFKB1 is linked to hepatocellular carcinoma.